| Target Price | $2.52 |
| Price | $13.28 |
| Deviation | |
| Number of Estimates | 4 |
| 4 Analysts have issued a price target Mesoblast Limited Sponsored ADR 2027 . The average Mesoblast Limited Sponsored ADR target price is $2.52. This is lower than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 10 analysts: 9 Analysts recommend Mesoblast Limited Sponsored ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Mesoblast Limited Sponsored ADR stock has an average upside potential 2027 of . Most analysts recommend the Mesoblast Limited Sponsored ADR stock at Purchase. |
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million $ | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
6 Analysts have issued a sales forecast Mesoblast Limited Sponsored ADR 2027 . The average Mesoblast Limited Sponsored ADR sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
6 Mesoblast Limited Sponsored ADR Analysts have issued a net profit forecast 2027. The average Mesoblast Limited Sponsored ADR net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
6 Analysts have issued a Mesoblast Limited Sponsored ADR forecast for earnings per share. The average Mesoblast Limited Sponsored ADR EPS is
. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Mesoblast Limited Sponsored ADR...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


